Skip to Content

US panel backs COVID-19 boosters only for elderly, high-risk

WASHINGTON (AP) — An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it approved the extra shots for those who are 65 or older or run a high risk of severe disease.

The twin votes Friday represented a heavy blow to the Biden administration’s sweeping effort to shore up nearly all Americans’ protection amid the spread of the highly contagious delta variant.

The decision was made by a committee of outside experts who advise the Food and Drug Administration.


WASHINGTON (AP) — An influential federal advisory panel has rejected a plan to offer Pfizer booster shots against COVID-19 to most Americans.

RELATED: FDA panel is first key test for Biden COVID-19 booster plan

The vote Friday, 61-3, was a blow to the Biden administration’s plan to shore up people’s protection against the virus amid the highly contagious delta variant.

Over several hours of discussion, members of the Food and Drug Administration panel of outside experts voiced frustration that Pfizer had provided little data on safety of extra doses.

And they complained that data provided by Israeli researchers about their booster campaign might not be suitable for predicting the U.S. experience.

Author Profile Photo

Associated Press

Skip to content